Literature DB >> 8104441

A hepatic invasive human colorectal xenograft model.

S A Watson, T M Morris, D M Crosbee, J D Hardcastle.   

Abstract

A hepatic invasive human colorectal xenograft model was derived in nude mice by selection through the liver of the parental cell line, C170. Following intraperitoneal injection, tumours selectively grew on the liver in > 80% of the animals within 15-20 days. The liver-invading xenograft line, renamed C170HM2, had a significantly greater expression of the Lewisx antigen compared to C170 (mean linear fluorescence per cell > 1000 compared with 500 for C170, P < 0.02). C170HM2 had significantly elevated proliferation (when compared with C170) in the presence of epidermal (P < 0.001) and basic fibroblast growth factor (P < 0.001). C170HM2 also mitogenically responded to type I collagen (derived from rat tails), unlike C170. C170HM2 tumours when invading the liver expressed both interstitial collagenase and gelatinase activity at the invading edge.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104441     DOI: 10.1016/0959-8049(93)90117-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Expression of the CD15 antigen (Lewis x) in breast cancer.

Authors:  S A Brooks; A J Leathem
Journal:  Histochem J       Date:  1995-09

2.  M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis.

Authors:  He Zhou; Sucharita Roy; Edward Cochran; Radouane Zouaoui; Chia Lin Chu; Jay Duffner; Ganlin Zhao; Sean Smith; Zoya Galcheva-Gargova; Juliane Karlgren; Nancy Dussault; Rain Y Q Kwan; Erick Moy; Marishka Barnes; Alison Long; Chris Honan; Yi Wei Qi; Zachary Shriver; Tanmoy Ganguly; Birgit Schultes; Ganesh Venkataraman; Takashi Kei Kishimoto
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

3.  Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.

Authors:  S A Watson; T M Morris; S L Parsons; R J Steele; P D Brown
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

4.  Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.

Authors:  E W Steyerberg; H J Keizer; S D Fosså; D T Sleijfer; D F Bajorin; J P Donohue; J D Habbema
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

5.  Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells.

Authors:  A M Grabowska; J Hughes; S A Watson
Journal:  Br J Cancer       Date:  2007-01-30       Impact factor: 7.640

6.  Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.

Authors:  H M Collins; T M Morris; S A Watson
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

7.  Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29.

Authors:  Philip Noble; Ian Spendlove; Stephen Harding; Tina Parsons; Lindy G Durrant
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

8.  Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.

Authors:  S A Watson; T M Morris; D F McWilliams; J Harris; S Evans; A Smith; P A Clarke
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.